Arcus Biosciences Inc (RCUS) — Financial Flexibility Index
Arcus Biosciences Inc (RCUS) has a Financial Flexibility Index of -0.29x as of March 2026. Free cash flow of $-138.00 Million (operating CF $-138.00 Million minus capex $0.00) represents 0% of total liabilities ($473.00 Million). Check Arcus Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arcus Biosciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Arcus Biosciences Inc across 10 annual periods. For the full cash flow conversion analysis, see Arcus Biosciences Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Arcus Biosciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Arcus Biosciences Inc. Explore cash flow to debt ratio of Arcus Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-480.00 Million | $-482.00 Million | $508.00 Million | ▼ -283.1% |
| 2024 | -0.25x | $-164.00 Million | $-170.00 Million | $665.00 Million | ▲ +44.6% |
| 2023 | -0.45x | $-282.00 Million | $-306.00 Million | $633.00 Million | ▼ -169.0% |
| 2022 | 0.65x | $444.00 Million | $438.00 Million | $688.00 Million | ▲ +310.5% |
| 2021 | -0.31x | $-230.09 Million | $-256.17 Million | $750.45 Million | ▼ -172.5% |
| 2020 | 0.42x | $114.22 Million | $111.17 Million | $269.99 Million | ▲ +123.2% |
| 2019 | -1.82x | $-71.54 Million | $-73.46 Million | $39.27 Million | ▼ -85.6% |
| 2018 | -0.98x | $-39.25 Million | $-43.00 Million | $39.98 Million | ▼ -83.9% |
| 2017 | -0.53x | $-19.55 Million | $-25.06 Million | $36.62 Million | ▲ +38.2% |
| 2016 | -0.86x | $-8.85 Million | $-12.94 Million | $10.24 Million | — |